Page last updated: 2024-10-22

antazoline and Eye Manifestations

antazoline has been researched along with Eye Manifestations in 1 studies

Antazoline: An antagonist of histamine H1 receptors.
antazoline : A member of the class of imidazolines that is 2-aminomethyl-2-imidazoline in which the exocyclic amino hydrogens are replaced by benzyl and phenyl groups. Antazoline is only found in individuals that have taken the drug.

Eye Manifestations: Ocular disorders attendant upon non-ocular disease or injury.

Research Excerpts

ExcerptRelevanceReference
" Evaluation of response at various times after instillation of medication for lacrimation, conjunctival inflammation, pruritus, photophobia and pain showed naphazoline hydrochloride, antazoline phosphate and the combination product superior to placebo."9.04Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial. ( Miller, J; Wolf, EH, 1975)
" Evaluation of response at various times after instillation of medication for lacrimation, conjunctival inflammation, pruritus, photophobia and pain showed naphazoline hydrochloride, antazoline phosphate and the combination product superior to placebo."5.04Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial. ( Miller, J; Wolf, EH, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, J1
Wolf, EH1

Trials

1 trial available for antazoline and Eye Manifestations

ArticleYear
Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial.
    Annals of allergy, 1975, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Antazoline; Child; Clinical Trials as Topic; Conjunctivitis; Drug Combinati

1975